Showing results (1761-1770 of 3,638) with videos related to
Sort By:
Pageof 364
Breast (Edinburgh, Scotland)|January 31, 2021
Impact of radiation dose on complications among women with breast cancer who underwent breast reconstruction and post-mastectomy radiotherapy: A multi-institutional validation studySeung Yeun Chung, Jee Suk Chang, Kyung Hwan Shin, et al.Breast (Edinburgh, Scotland)|December 11, 2021
Are English-language online patient education materials related to breast cancer risk assessment understandable, readable, and actionable?Leslie R Lamb, Grayson L Baird, Ishita T Roy, et al.Breast (Edinburgh, Scotland)|January 18, 2022
Prognosis of triple-negative breast cancer associated with pregnancy: A propensity score-matched analysis from the French CALG (Cancer Associé à la Grossesse) networkAnne Puchar, Marie Despierres, Anne-Sophie Boudy, et al.Breast (Edinburgh, Scotland)|January 7, 2022
Statin use and patterns of breast cancer recurrence in the Malmö Diet and Cancer StudyMaria Inasu, Maria Feldt, Helena Jernström, et al.Breast (Edinburgh, Scotland)|January 8, 2022
Immune checkpoint inhibition in the treatment of early stage triple negative breast cancer: 2021 updateLauren C Brown, Sherene LoiBreast (Edinburgh, Scotland)|May 6, 2008
Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32,825 patientsR Stuart-Harris, C Caldas, S E Pinder, et al.Breast (Edinburgh, Scotland)|May 6, 2008
Possibilities for transborder cooperation in breast cancer care in Europe: a comparative analysis regarding the content, quality and evidence use of breast cancer guidelinesL Wennekes, R P M G Hermens, K van Heumen, et al.Breast (Edinburgh, Scotland)|May 6, 2008
Personal growth and psychological distress in advanced breast cancerKyriaki Mystakidou, Eleni Tsilika, Efi Parpa, et al.Breast (Edinburgh, Scotland)|May 6, 2008
Topoisomerase IIalpha gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancerLaura Orlando, Barbara Del Curto, Sara Gandini, et al.Pageof 364